Healthtech Investors & VC Firms in Europe
1121 firms in this list, with a median first check of $540K. 275 of them lead rounds. Generated from verified public data and updated continuously.
Biomark Capital
GreenwichSeries A–Late Stage$5M – $10M
4 people
ExtraVallis
Coral GablesPre-Seed–Series A
Fosun Pharma
Shanghai
Mankind Pharma
New DelhiSeries A
Capitalworks
JohannesburgGrowth–Late Stage
Equestrus
VancouverPre-Seed–Growth$1.1M
eureKARE
Seed
NF Trinity
Hong KongSeed–Growth
World Innovation Lab (WiL)
Palo AltoPre-Seed–Late Stage$5M – $30M
IDO Investments
MuscatSeries A–Late Stage$2.3M – $140M
10x Genomics
Pleasanton
4 people
Impact Ventures
Palo AltoSeed–Series B
3 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$1M – $30M
Brandon Capital Partners
MelbourneSeed–Growth
1 person
Chandaria Capital
NairobiPre-Seed–Growth
KM Capital
AustinPre-Seed–Series A
Swiss Re Ventures
New YorkSeed–Growth
Related lists
Investors & VC Firms in North America (13845)Investors & VC Firms in United States (12980)Investors & VC Firms in Europe (5528)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4182)SaaS Investors & VC Firms (3878)AI & Machine Learning Investors & VC Firms (3817)Fintech Investors & VC Firms (3737)Investors & VC Firms in Asia-Pacific (3575)Healthtech Investors & VC Firms (3445)
Data sourced from public filings and firms' own websites — see our methodology.






